X0306 4 2016-01-04 0 0000891293 CTI BIOPHARMA CORP ctic 0001557551 Plunkett Matthew 3101 WESTERN AVENUE, SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Chief Business Officer Common Stock 2016-01-04 4 S 0 1600 1.195 D 618484 D Common Stock 2016-01-04 4 S 0 1898 1.2 D 616586 D Common Stock 2016-01-04 4 S 0 800 1.205 D 615786 D Common Stock 2016-01-04 4 S 0 1900 1.21 D 613886 D Common Stock 2016-01-04 4 S 0 1700 1.22 D 612186 D Common Stock 2016-01-04 4 S 0 800 1.23 D 611386 D Common Stock 2016-01-04 4 S 0 300 1.235 D 611086 D Common Stock 2016-01-04 4 S 0 202 1.24 D 610884 D Common Stock 2016-01-04 4 S 0 600 1.25 D 610284 D Common Stock 2016-01-04 4 S 0 200 1.26 D 610084 D The sale was effected pursuant to a Rule 10b5-1 trading plan. By: Louis A. Bianco, Attorney-in-fact For: Matthew Plunkett 2016-01-06